The authors analyzed the expression of erythroferrone and growth/differentiation factor 15 in CD71+ erythroid progenitors of 111 myelodysplastic syndrome patients and assessed their effects on patient survival.
[British Journal of Haematology]
Riabov, V., Mossner, M., Stöhr, A., Jann, J.-C., Streuer, A., Schmitt, N., Knaflic, A., Nowak, V., Weimer, N., Obländer, J., Palme, I., Schumann, C., Baldus, C. D., Schulze, T. J., Wuchter, P., Röhl, H., Jawhar, A., Weiss, C., Boch, T., … Nowak, D. (n.d.). High erythroferrone expression in CD71+ erythroid progenitors predicts superior survival in myelodysplastic syndromes. British Journal of Haematology, n/a(n/a). https://doi.org/https://doi.org/10.1111/bjh.17314 Cite
0